| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |